Pharma Struggles To Escape FCPA Net
By Samuel Howard · November 23, 2010, 7:30 PM EST
The U.S. government's Foreign Corrupt Practices Act investigation of the pharmaceutical industry exposes major drugmakers to untold risks and gives executives the Herculean task of controlling the way business is conducted...
To view the full article, register now.